Abstract: A composition for prophylaxis and therapy of dermal aging which comprises a substance having human leukocyte elastase inhibitory activity as an active ingredient.

Abstract: A composition for prophylaxis and therapy of dermal aging which comprises a substance having human leukocyte elastase inhibitory activity as an active ingredient.

Abstract: A rotary dryer for drying and mixing particulate material, includes a shell having a pair of conical portions and provided with a jacket to which a hot fluid may be fed, the shell defining a chamber for the material to be dried and mixed. An air-tight closure for the chamber is provided with a jacket to which hot fluid may be fed and through which the material is charged and discharged. A rotary tube shaft extends horizontally from one end of the shell and along the horizontal axis of the shell, the rotary tube shaft being sheathed by a rotary joint pipe equipped with a bearing rotatably supporting the rotary tube shaft. The rotary tube shaft is provided with a plurality of communication paths which communicate with charge/discharge ports located on the rotary joint pipe during rotation of the rotary tube shaft in the rotary joint pipe, the communication paths connecting the jackets of the shell and the closure for feeding the hot fluid.

Abstract: Pharmaceutical preparation containing an acid labile compound together with an alkaline reacting compound or an alkaline salt of an acid labile compound optionally together with an alkaline compound as the core material, one or more subcoating layers comprising inert reacting compounds which are soluble or rapidly disintegrating in water, or polymeric, water soluble filmforming compounds, optionally containing pH-buffering alkaline compounds and an enteric coating as well as a process for the preparation thereof and the use in the treatment of gastrointestinal diseases.

Abstract: Pharmaceutical preparation containing omeprazole together with an alkaline reacting compound or an alkaline salt of omeprazole optionally together with an alkaline compound as the core material, one or more subcoating layers comprising inert reacting compounds which are soluble or rapidly disintegrating in water, or polymeric, water soluble filmforming compounds, optionally containing pH-buffering alkaline compounds and an enteric coating as well as a process for the preparation thereof and the use in the treatment of gastrointestinal diseases.

Abstract: The present invention relates to a long active pharmaceutical composition of Tiaramide or its pharmaceutically acceptable salt which comprises Tiaramide or its pharmaceutically acceptable salt as an active ingredient and a water particularly insoluble substance which melts with warming or heating.